FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1019-1022 September 26, 2002 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hurlen, M. PubMed Citation

Despite encouraging trends over the past three decades, coronary heart disease remains the leading cause of death in the United States and other industrialized countries. Recent data from the National Center for Health Statistics and the National Heart, Lung, and Blood Institute¹ emphasize the full dimensions of this health problem, revealing that nearly 13 million Americans have coronary heart disease and that 7.5 million have had a myocardial infarction. Because there are 1.1 million myocardial infarctions in the United States alone each year and because 450,000 of them represent recurrent infarctions, which carry an inherently greater risk of death and . . . [Full Text of this Article]

Related Letters:

Warfarin, Aspirin, or Both after Myocardial Infarction
Pullicino P., Thompson J. L.P., Amit G., Ilia R., Zahger D., Aronow W. S., Hurlen M., Arnesen H., Smith P.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:256-257, Jan 16, 2003. Correspondence

This article has been cited by other articles:

• Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A. (2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 776S-814S [Abstract] [Full Text]  
• Husted, S.E., Ziegler, B.K., Kher, A. (2006). Long-term anticoagulant therapy in patients with coronary artery disease. Eur Heart J 27: 913-919 [Abstract] [Full Text]  
• Herlitz, J., Holm, J., Peterson, M., Karlson, B. W, Haglid Evander, M., Erhardt, L., for the LoWASA study group, (2004). Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction: the LoWASA Study. Eur Heart J 25: 232-239 [Abstract] [Full Text]  
• Jeddy, A. S, Gleason, B. L (2003). Aspirin and Warfarin Versus Aspirin Monotherapy After Myocardial Infarction. The Annals of Pharmacotherapy 37: 1502-1505 [Abstract] [Full Text]  
• Schulman, S. (2003). Care of Patients Receiving Long-Term Anticoagulant Therapy. NEJM 349: 675-683 [Full Text]  
• Eikelboom, J. W., Hankey, G. J. (2003). Aspirin resistance:a new independent predictor of vascular events?. J Am Coll Cardiol 41: 966-968 [Full Text]  
• Pullicino, P., Thompson, J. L.P., Amit, G., Ilia, R., Zahger, D., Aronow, W. S., Hurlen, M., Arnesen, H., Smith, P. (2003). Warfarin, Aspirin, or Both after Myocardial Infarction. NEJM 348: 256-257 [Full Text]  
• (2002). More Data for the Post-MI Warfarin vs. Aspirin Debate. Journal Watch Cardiology 2002: 1-1 [Full Text]  
• (2002). Another Study of Anticoagulation After MI. JWatch General 2002: 1-1 [Full Text]